Logo image of BCPC

BALCHEM CORP (BCPC) Stock Fundamental Analysis

NASDAQ:BCPC - Nasdaq - US0576652004 - Common Stock - Currency: USD

161.03  +0.14 (+0.09%)

After market: 161.03 0 (0%)

Fundamental Rating

6

BCPC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. BCPC scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BCPC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year BCPC was profitable.
BCPC had a positive operating cash flow in the past year.
Each year in the past 5 years BCPC has been profitable.
In the past 5 years BCPC always reported a positive cash flow from operatings.
BCPC Yearly Net Income VS EBIT VS OCF VS FCFBCPC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

1.2 Ratios

With an excellent Return On Assets value of 7.61%, BCPC belongs to the best of the industry, outperforming 86.59% of the companies in the same industry.
BCPC has a Return On Equity of 10.32%. This is in the better half of the industry: BCPC outperforms 68.29% of its industry peers.
BCPC has a Return On Invested Capital of 9.15%. This is amongst the best in the industry. BCPC outperforms 84.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BCPC is above the industry average of 6.57%.
The last Return On Invested Capital (9.15%) for BCPC is above the 3 year average (8.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.61%
ROE 10.32%
ROIC 9.15%
ROA(3y)7.1%
ROA(5y)7.09%
ROE(3y)10.83%
ROE(5y)10.68%
ROIC(3y)8.66%
ROIC(5y)8.42%
BCPC Yearly ROA, ROE, ROICBCPC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10

1.3 Margins

The Profit Margin of BCPC (12.90%) is better than 91.46% of its industry peers.
In the last couple of years the Profit Margin of BCPC has remained more or less at the same level.
BCPC has a better Operating Margin (18.30%) than 89.02% of its industry peers.
In the last couple of years the Operating Margin of BCPC has remained more or less at the same level.
The Gross Margin of BCPC (34.47%) is better than 68.29% of its industry peers.
BCPC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.3%
PM (TTM) 12.9%
GM 34.47%
OM growth 3Y1.9%
OM growth 5Y0.1%
PM growth 3Y-0.72%
PM growth 5Y-0.74%
GM growth 3Y0.96%
GM growth 5Y0.63%
BCPC Yearly Profit, Operating, Gross MarginsBCPC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BCPC is creating some value.
Compared to 1 year ago, BCPC has about the same amount of shares outstanding.
Compared to 5 years ago, BCPC has about the same amount of shares outstanding.
Compared to 1 year ago, BCPC has an improved debt to assets ratio.
BCPC Yearly Shares OutstandingBCPC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
BCPC Yearly Total Debt VS Total AssetsBCPC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 9.46 indicates that BCPC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.46, BCPC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Debt to FCF ratio of BCPC is 1.41, which is an excellent value as it means it would take BCPC, only 1.41 years of fcf income to pay off all of its debts.
BCPC's Debt to FCF ratio of 1.41 is amongst the best of the industry. BCPC outperforms 91.46% of its industry peers.
BCPC has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
BCPC has a Debt to Equity ratio of 0.19. This is in the better half of the industry: BCPC outperforms 79.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.41
Altman-Z 9.46
ROIC/WACC1.03
WACC8.92%
BCPC Yearly LT Debt VS Equity VS FCFBCPC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.98 indicates that BCPC has no problem at all paying its short term obligations.
BCPC's Current ratio of 2.98 is amongst the best of the industry. BCPC outperforms 82.93% of its industry peers.
BCPC has a Quick Ratio of 1.90. This is a normal value and indicates that BCPC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.90, BCPC is in the better half of the industry, outperforming 74.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 1.9
BCPC Yearly Current Assets VS Current LiabilitesBCPC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

4

3. Growth

3.1 Past

BCPC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.53%.
Measured over the past 5 years, BCPC shows a small growth in Earnings Per Share. The EPS has been growing by 5.73% on average per year.
Looking at the last year, BCPC shows a small growth in Revenue. The Revenue has grown by 1.75% in the last year.
BCPC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.46% yearly.
EPS 1Y (TTM)5.53%
EPS 3Y6.32%
EPS 5Y5.73%
EPS Q2Q%8.65%
Revenue 1Y (TTM)1.75%
Revenue growth 3Y9.45%
Revenue growth 5Y7.46%
Sales Q2Q%4.35%

3.2 Future

The Earnings Per Share is expected to grow by 9.60% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.35% on average over the next years.
EPS Next Y11.33%
EPS Next 2Y11.75%
EPS Next 3Y9.6%
EPS Next 5YN/A
Revenue Next Year2.72%
Revenue Next 2Y4.64%
Revenue Next 3Y4.35%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BCPC Yearly Revenue VS EstimatesBCPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
BCPC Yearly EPS VS EstimatesBCPC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.34, the valuation of BCPC can be described as expensive.
65.85% of the companies in the same industry are cheaper than BCPC, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.39. BCPC is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 32.32, which means the current valuation is very expensive for BCPC.
Based on the Price/Forward Earnings ratio, BCPC is valued a bit more expensive than the industry average as 69.51% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 24.37. BCPC is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 38.34
Fwd PE 32.32
BCPC Price Earnings VS Forward Price EarningsBCPC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BCPC's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. BCPC is more expensive than 81.71% of the companies in the same industry.
BCPC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 32.21
EV/EBITDA 24.09
BCPC Per share dataBCPC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BCPC does not grow enough to justify the current Price/Earnings ratio.
BCPC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.38
PEG (5Y)6.69
EPS Next 2Y11.75%
EPS Next 3Y9.6%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.54%, BCPC is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.21, BCPC is paying slightly less dividend.
With a Dividend Yield of 0.54, BCPC pays less dividend than the S&P500 average, which is at 2.27.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

The dividend of BCPC is nicely growing with an annual growth rate of 11.23%!
BCPC has paid a dividend for at least 10 years, which is a reliable track record.
BCPC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.23%
Div Incr Years14
Div Non Decr Years25
BCPC Yearly Dividends per shareBCPC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

21.02% of the earnings are spent on dividend by BCPC. This is a low number and sustainable payout ratio.
BCPC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP21.02%
EPS Next 2Y11.75%
EPS Next 3Y9.6%
BCPC Yearly Income VS Free CF VS DividendBCPC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
BCPC Dividend Payout.BCPC Dividend Payout, showing the Payout Ratio.BCPC Dividend Payout.PayoutRetained Earnings

BALCHEM CORP

NASDAQ:BCPC (1/28/2025, 4:30:00 PM)

After market: 161.03 0 (0%)

161.03

+0.14 (+0.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-25 2024-10-25/bmo
Earnings (Next)02-14 2025-02-14/amc
Inst Owners90.66%
Inst Owner Change-0.3%
Ins Owners0.36%
Ins Owner Change-0.11%
Market Cap5.24B
Analysts82.5
Price Target194.14 (20.56%)
Short Float %1.48%
Short Ratio3.54
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend0.71
Dividend Growth(5Y)11.23%
DP21.02%
Div Incr Years14
Div Non Decr Years25
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.53%
Min EPS beat(2)-0.19%
Max EPS beat(2)3.25%
EPS beat(4)3
Avg EPS beat(4)1.56%
Min EPS beat(4)-0.19%
Max EPS beat(4)3.25%
EPS beat(8)7
Avg EPS beat(8)9.66%
EPS beat(12)10
Avg EPS beat(12)10.96%
EPS beat(16)14
Avg EPS beat(16)8.96%
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-4.25%
Max Revenue beat(2)-2.77%
Revenue beat(4)1
Avg Revenue beat(4)-2.6%
Min Revenue beat(4)-4.45%
Max Revenue beat(4)1.08%
Revenue beat(8)1
Avg Revenue beat(8)-3.75%
Revenue beat(12)4
Avg Revenue beat(12)-1.14%
Revenue beat(16)7
Avg Revenue beat(16)-0.4%
PT rev (1m)0%
PT rev (3m)0.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE 38.34
Fwd PE 32.32
P/S 5.56
P/FCF 32.21
P/OCF 26.57
P/B 4.45
P/tB 23.95
EV/EBITDA 24.09
EPS(TTM)4.2
EY2.61%
EPS(NY)4.98
Fwd EY3.09%
FCF(TTM)5
FCFY3.1%
OCF(TTM)6.06
OCFY3.76%
SpS28.99
BVpS36.21
TBVpS6.72
PEG (NY)3.38
PEG (5Y)6.69
Profitability
Industry RankSector Rank
ROA 7.61%
ROE 10.32%
ROCE 11.59%
ROIC 9.15%
ROICexc 9.62%
ROICexgc 29.89%
OM 18.3%
PM (TTM) 12.9%
GM 34.47%
FCFM 17.25%
ROA(3y)7.1%
ROA(5y)7.09%
ROE(3y)10.83%
ROE(5y)10.68%
ROIC(3y)8.66%
ROIC(5y)8.42%
ROICexc(3y)9.26%
ROICexc(5y)9.02%
ROICexgc(3y)29%
ROICexgc(5y)27.74%
ROCE(3y)10.97%
ROCE(5y)10.67%
ROICexcg growth 3Y3.97%
ROICexcg growth 5Y0.01%
ROICexc growth 3Y-0.38%
ROICexc growth 5Y-2.54%
OM growth 3Y1.9%
OM growth 5Y0.1%
PM growth 3Y-0.72%
PM growth 5Y-0.74%
GM growth 3Y0.96%
GM growth 5Y0.63%
F-Score7
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.41
Debt/EBITDA 1.02
Cap/Depr 67.55%
Cap/Sales 3.66%
Interest Coverage 8.48
Cash Conversion 88.15%
Profit Quality 133.71%
Current Ratio 2.98
Quick Ratio 1.9
Altman-Z 9.46
F-Score7
WACC8.92%
ROIC/WACC1.03
Cap/Depr(3y)80.85%
Cap/Depr(5y)74.06%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.67%
Profit Quality(3y)115.39%
Profit Quality(5y)120.94%
High Growth Momentum
Growth
EPS 1Y (TTM)5.53%
EPS 3Y6.32%
EPS 5Y5.73%
EPS Q2Q%8.65%
EPS Next Y11.33%
EPS Next 2Y11.75%
EPS Next 3Y9.6%
EPS Next 5YN/A
Revenue 1Y (TTM)1.75%
Revenue growth 3Y9.45%
Revenue growth 5Y7.46%
Sales Q2Q%4.35%
Revenue Next Year2.72%
Revenue Next 2Y4.64%
Revenue Next 3Y4.35%
Revenue Next 5YN/A
EBIT growth 1Y13.21%
EBIT growth 3Y11.52%
EBIT growth 5Y7.57%
EBIT Next Year51.71%
EBIT Next 3Y16.03%
EBIT Next 5YN/A
FCF growth 1Y79.38%
FCF growth 3Y7.72%
FCF growth 5Y8.06%
OCF growth 1Y39.35%
OCF growth 3Y6.88%
OCF growth 5Y9.13%